Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Squamous Cell Carcinoma of Head and Neck 8Oropharyngeal Neoplasms 6Lung Neoplasms 5Mesothelioma, Malignant 4Laryngeal Neoplasms 4Uterine Cervical Neoplasms 3Urinary Bladder Neoplasms 3Mouth Neoplasms 3Hypopharyngeal Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Triple Negative Breast Neoplasms 2Small Cell Lung Carcinoma 2Salivary Gland Neoplasms 2Prostatic Neoplasms 2Paranasal Sinus Neoplasms 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Nasopharyngeal Carcinoma 2Medulloblastoma 2Lymphoid Interstitial Pneumonia 2Gallbladder Neoplasms 2Fallopian Tube Neoplasms 2Carcinoma 2Breast Neoplasms 2Vaginal Neoplasms 1Urethral Neoplasms 1Tongue Neoplasms 1Solitary Fibrous Tumor, Pleural 1Sinonasal undifferentiated carcinoma 1SCLC 1

Interventions

pembrolizumab 2venetoclax 1taxane 1sargramostim 1rucaparib 1olaparib 1lentiviral minigene vaccine of COVID-19 coronavirus 1Platinum 1Patient Reported Outcome Measures 1Paclitaxel 1Observation 1Nivolumab 1Monatide (IMS 3015) 1Granulocyte-Macrophage Colony-Stimulating Factor 1Epirubicin 1Decitabine 1Cytarabine 1Cyclophosphamide 1Carboplatin 1Capecitabine 1Azacitidine 1Antimetabolites 1Anthracyclines 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Pathologic Complete Response × Platinum × Clear all
NCT04335669 2025-09-12

NordicTrip, a Translational Study of Preoperative Chemotherapy in TNBC

Lund University Hospital

Phase 3 Active not recruiting
325 enrolled
Breast

Pathologic Complete Response, Breast Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡